Skip to content

Drug interactions

Regorafenib + Sofosbuvir / velpatasvir

Severity: Moderate

Regorafenib and Sofosbuvir / velpatasvir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Regorafenib may inhibit BCRP and increase exposure to sofosbuvir and velpatasvir. The clinical significance is uncertain.

What this interaction means in plain words

Regorafenib and Sofosbuvir / velpatasvir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Regorafenib inhibits BCRP and P-gp efflux of sofosbuvir and velpatasvir.

What to do

Monitor for antiviral adverse effects and liver function. No empiric dose change is established.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Regorafenib and Sofosbuvir / velpatasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Regorafenib with Sofosbuvir / velpatasvir?

MediHelp rates the interaction as moderate. Regorafenib and Sofosbuvir / velpatasvir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Regorafenib may inhibit BCRP and increase exposure to sofosbuvir and velpatasvir. The clinical significance is uncertain.

How serious is the interaction between Regorafenib and Sofosbuvir / velpatasvir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for antiviral adverse effects and liver function. No empiric dose change is established.

What other medicines interact with Regorafenib?

MediHelp also lists interactions of Regorafenib with, for example, Apalutamide, Atazanavir, Carbamazepine. The full list is on the Regorafenib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in